Evidence map›Paper›PMID 40636156›Full record

ArticleBioscience of microbiota, food and health2025

Tomoaki Naito, Masatoshi Morikawa, Ayaka Maki, Noriko Kato-Nagaoka, Yuya Hagihira, Akira Iwata, Osamu Watanabe, Kan Shida, Satoshi Matsumoto, Tetsuji Hori

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioscience of microbiota, food and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tomoaki NaitoYakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.
Masatoshi MorikawaYakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.
Ayaka MakiYakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.
Noriko Kato-NagaokaYakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.
Yuya HagihiraYakult Honsha Co., Ltd., 1-10-30 Kaigan, Minato-ku, Tokyo 105-8660, Japan.
Akira IwataYakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.
Osamu WatanabeYakult Honsha Co., Ltd., 1-10-30 Kaigan, Minato-ku, Tokyo 105-8660, Japan.
Kan ShidaYakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.
Satoshi MatsumotoYakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.
Tetsuji HoriYakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Certain probiotics prevent upper respiratory tract infections (URTIs) by activating immune cells, particularly mononuclear phagocytic cells (MPCs). However, the influence of

Indexed as

dendritic cellHLA-DRLacticaseibacillus paracasei strain Shirota (LcS)monocyteupper respiratory tract infections (URTIs)

Identifiers

PMID40636156
PMCPMC12236165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.